Sustainability & Climate

Closing 2025 with two major acquisitions, The Milestone Group signals a larger investor trend: a strategic rush into the booming Mountain West.

Aerospace veteran John Slattery brings his expertise to Orbis International, aiming to elevate the mission of its unique Flying Eye Hospital.

With star hires and proprietary data analytics, Abacus Global Management is making an ambitious play for the booming asset-based finance sector.

With its first drug approved and a deep pipeline, all eyes are on Nuvation Bio's CEO David Hung at the upcoming J.P. Morgan Healthcare Conference.

UBC's strategic acquisition of Evidinno creates a new powerhouse in biopharma evidence, combining global scale with AI-driven health economic insights.

A landmark trial reveals a new drug combination from BeOne Medicines extends life significantly in advanced stomach cancer, poised to become the new standard.

For the fourth straight year, HRL Labs is a top workplace. Discover how its unique R&D culture and strategic vision set it apart in a competitive market.

A new nationwide study reveals a massive gap in care for heart failure patients, costing lives and billions. Why are proven, cheap medications being overlooked?

A prominent healthcare executive is using his personal resources to empower students to develop actionable solutions for combating intolerance and hate.

With new funding, the foundation aims to empower nurses on the front lines, fueling solutions for healthcare's most vulnerable populations.

A new national scholarship from a Las Vegas physician looks beyond grades, using essays to find future doctors committed to ethical service and community care.

The world's biggest music and AI giants partner to revolutionize music discovery and creation, promising an artist-centric approach to end generic AI content.

A promising antiviral combination for Long COVID gets a major boost, accelerating its path to a pivotal clinical trial led by top researchers.

Circana's new AI-powered platform, Liquid Testing, promises to slash retail testing times from months to days, helping brands avoid costly failures.

A U.S. lumber group refutes claims that tariffs drive up home prices, arguing Canada's unfair trade practices are the real issue in the ongoing dispute.

A new report shows U.S. farmers are increasingly wary of the future, as Brazilian competition and trade policy uncertainty overshadow strong land values.

The cybersecurity firm becomes the first in its niche to reach Centaur status, highlighting a major industry shift from reactive fixes to automated validation.

The security tech firm expands its domestic violence monitoring to a 10th nation, signaling a major shift in Europe's public safety technology market.

With major clinical trials, including a novel approach for Alzheimer's, and key market access wins, MMI's Symani system is poised to redefine microsurgery.

Built In names its 2026 top workplaces, but as AI reshapes hiring, a critical look reveals what these accolades truly mean for your career.